Senior insider sale
Chief People Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$6.42M
235.92K shares
What this filing means
ANDERSON KAREN M. plans to sell 235.92K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $6.42M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/26/2026ACC: 0001969223-26-000398
Officer· Chief People Officer
Since Mar 2026
235.92K
Shares to sell
$6.42M
Approx. market value
41.08K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
CASH
3/26/2026
41.08KTotal acquired41.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2026 | Exercise of Stock Options CASH | 41.08K | — |
| Total | 41.08K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
10.04K
Market value
$282.2K
3/17/2026
—Completed
Units to sell
64.77K
Market value
$1.83M
3/16/2026
—Completed
Units to sell
120.03K
Market value
$3.15M
3/13/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
41.08K
Market value
$1.16M
3/26/2026
Total
Units
235.92K
Value
$6.42M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 10.04K | $282.2K | — | Completed |
3/16/2026 | 64.77K | $1.83M | — | Completed |
3/13/2026 | 120.03K | $3.15M | — | Completed |
| Planned — Approximate Date | ||||
3/26/2026 | 41.08K | $1.16M | Nasdaq | Planned |
| Total | 235.92K | $6.42M | ||